Bio-IT World September 14, 2022
Deborah Borfitz

In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information. In fact, the opposite is true, according to Kayte Spector-Bagdady, J.D., associate director of the Center for Bioethics & Social Sciences in Medicine at Michigan Medicine.

Writing in a research letter published in JAMA (DOI: 10.1001/jama.2022.9740), she and her colleagues report that a proportionately greater number of people are interested in notification if their health information will be used than if their biospecimen will be, and this is particularly true if...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Patient / Consumer, Privacy / Security
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article